← SynDRA
LIDAMIDINE
SynDRA canonical compound SYN0002164 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | diarrhea |
|---|
| Disease area | gastroenterology |
|---|
Mechanisms of action (all sources)
- adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD2
- ADORA1
- HRH2
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PKM
- POLI
- PTGS2
- SCN5A
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH3
- HRH1
- ADORA2A
- HDAC6
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Antidiarrheals
- Gastrointestinal Agents
- Neurotransmitter Agents
Cross-references
Synonyms
- lidamidine monohydrochloride
- WHR-1142A
- lidamidine hydrochloride
- lidamidine HCl
- Lidamidina
- Lidamidine [INN]
- N-(2,6-Dimethylphenyl)-N'-(imino(methylamino)methyl)urea
- 1-(2,6-dimethylphenyl)-3-(N'-methylcarbamimidoyl)urea
- 2-[({[imino(methylamino)methyl]amino}carbonyl)amino]-1,3-dimethylbenzene
- Lidamidine (INN)
- 1-(2,6-dimethylphenyl)-3-(N-methylcarbamimidoyl)urea
- Q8X04W8418
- NCGC00160661-01
- Urea, N-(2,6-dimethylphenyl)-N'-(imino(methylamino)methyl)-
- Lidamidinum
- Urea, N-(2,6-dimethylphenyl)-N'-[imino(methylamino)methyl]-
- Urea,N-(2,6-dimethylphenyl)-N'-[imino(methylamino)methyl]-
- Lidamidinum [INN-Latin]
- Lidamidina [INN-Spanish]
- CAS-66871-56-5
- UNII-Q8X04W8418
- LIDAMIDINE [MI]
- TimTec1_004303
- LIDAMIDINE [WHO-DD]
- SCHEMBL122710
- CHEMBL448416
- DTXSID4049080
- CHEBI:134907
- HMS1546D13
- Tox21_113641
- MFCD00449519
- STK095480
- ZINC13115357
- AKOS001737102
- Tox21_113641_1
- MS-3109
- NCGC00160661-02
Look up LIDAMIDINE in the interactive SynDRA portal →